EPO906 Therapy in Patients With Advanced Kidney Cancer
NCT00035243
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Kidney Neoplasms
Interventions
DRUG:
epothilone b
Sponsor
Novartis Pharmaceuticals